Zhang H D, Gong S C, Sun K, Wang H, Zhou L J, Yan Y F, Liu K, Lyu X J, Yu Z K
Clinical Medicine Department, School of Medicine, Southeast University, Nanjing 210096, China Department of Otorhinolaryngology and Head and Neck Surgery, BenQ Medical Center, the Affiliated BenQ Hospital of Nanjing Medical University, Nanjing 210019, China Nanjing Medical Key Laboratory of Laryngopharynx-Head & Neck Oncology, Nanjing 210019, China.
Department of Otorhinolaryngology and Head and Neck Surgery, BenQ Medical Center, the Affiliated BenQ Hospital of Nanjing Medical University, Nanjing 210019, China Nanjing Medical Key Laboratory of Laryngopharynx-Head & Neck Oncology, Nanjing 210019, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Aug 7;59(8):850-856. doi: 10.3760/cma.j.cn115330-20240226-00107.
To explore the surgical intervention strategy for metastatic cervical lymph nodes surrounding the carotid artery in head and neck squamous cell carcinoma. A total of 62 patients with advanced head and neck tumors and carotid wrap by disease treated in Department of Otorhinolaryngology and Head and Neck Surgery, the Affiliated BenQ Hospital of Nanjing Medical University between June 2019 and December 2023 were reviewed, of whom 9 patients presented with metastatic squamous cell carcinoma in cervical lymph nodes of unknown primary or with no recurrence of primary lesion and all the 9 patients were males, aged from 48 to 79 years old, with≤level 2 of Eastern Cooperative Oncology Group-Performance Status (ECOG-PS). Radiographically common carotid artery (CCA) and/or internal carotid artery (ICA) were surrounded by≥270° with tumor. All the 9 patients received implantation of covered stent in carotid artery and radical resection of metastatic cervical lymph nodes. The success rate, complications, surgery-related complications, local recurrence rate, quality of life (QOL) and overall survival (OS) were analyzed. The QOL of patients was compared by paired rank sum test, and <0.05 indicated statistically significant difference. The OS was analyzed by Kaplan-Meier. The success rate of stent implantation was 100%, with no implantation-related complications. R0 resection was performed in 8 cases and R1 resection in 1 case. The QOL of patients after surgery was improved, and the improvements in "pain", "mood" and "anxiety" were statistically significant( values were -2.236, -2.460 and -2.200, respectively, and all values were<0.05). Follow-up was 1-18 months, with a median of 7 months, and 1 case was lost to follow-up. Local recurrence occurred in 3 patients with an incidence of 37.5% (3/8). OS was 59.9% at 12 months after surgery. Implantation of covered stent in carotid artery combined with radical resection is an effective method for the treatment of cervical lymph node metastasis.
探讨头颈部鳞状细胞癌中围绕颈动脉的转移性颈淋巴结的手术干预策略。回顾性分析2019年6月至2023年12月在南京医科大学附属明基医院耳鼻咽喉头颈外科治疗的62例晚期头颈部肿瘤且病变累及颈动脉包裹的患者,其中9例患者表现为不明原发灶的颈部淋巴结转移性鳞状细胞癌或原发灶无复发,且9例患者均为男性,年龄48至79岁,东部肿瘤协作组体能状态(ECOG-PS)≤2级。影像学检查显示颈总动脉(CCA)和/或颈内动脉(ICA)被肿瘤环绕≥270°。9例患者均接受了颈动脉带膜支架植入及转移性颈淋巴结根治性切除术。分析成功率、并发症、手术相关并发症、局部复发率、生活质量(QOL)和总生存期(OS)。采用配对秩和检验比较患者的生活质量,P<0.05表示差异有统计学意义。采用Kaplan-Meier法分析总生存期。支架植入成功率为100%,无植入相关并发症。8例行R0切除,1例行R1切除。患者术后生活质量得到改善,“疼痛”“情绪”和“焦虑”方面的改善有统计学意义(P值分别为-2.236、-2.460和-2.200,均P<0.05)。随访1至18个月,中位随访时间7个月,1例失访。3例发生局部复发,发生率为37.5%(3/8)。术后12个月总生存率为59.9%。颈动脉带膜支架植入联合根治性切除术是治疗颈部淋巴结转移的有效方法。